DOCSLIB.ORG

Female Pattern Hair Loss

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Female Pattern Hair Loss CLINICAL Female pattern hair loss Linda Chan, David K Cook APPROXIMATELY 49% of women will be host of underlying or contributing medical affected by hair loss throughout their and psychiatric conditions. All causes lives, with female pattern hair loss of hyperandrogenism, such as ovarian Background (FPHL) being the most common cause of or adrenal tumours, polycystic ovarian Female pattern hair loss (FPHL) is female alopecia.1 The incidence steadily syndrome and adrenal hyperplasia, can a commonly encountered clinical increases with age in all ethnicities, and induce rapid hair loss in women. The presentation in primary care. Patterned hair loss in women is characterised the age-adjusted prevalence among adult diagnosis of FPHL is associated with by diffuse hair thinning and often Australian women of European descent underlying hypertension in women aged becomes an ongoing cause of is >32%.1–4 This translates to 800,000 ≤35 years and coronary artery disease psychosocial distress. women who suffer from moderate-to- in women aged ≤50 years.7 One study severe FPHL.4 Alopecia is associated with found that patterned hair loss was an Objectives significant psychological distress and independent predictor of mortality from The aim of this article is to present a practical approach for the clinical reduced quality of life. In one survey, 40% diabetes mellitus and heart disease in assessment of female hair loss and of women experienced marital problems both females and males.7–9 Screening to review the up-to-date treatment and 64% had career difficulties that they for metabolic cardiovascular risk factors modalities. ascribed to their hair loss.5 Alopecia can is useful in patients presenting with also be the first symptom of underlying patterned hair loss.3,10 Discussion Alopecia can be the first symptom of systemic illness within the primary 1,6 systemic illness. It is therefore crucial care setting. Risk factors for the primary care physician to be FPHL is a non-scarring alopecia able to differentiate between FPHL characterised by progressive transformation The risk factors for FPHL include increasing and more concerning causes of hair of thick, pigmented terminal hair into age, family history, smoking, elevated loss. Treatment options often involve short, thin, non-pigmented villous hair. fasting glucose levels and ultraviolet light a combination of non-androgenic This undesired process is known as hair exposure of >16 hours/week.8 and androgenic therapy. The use of 1,3,5,6 oral minoxidil in combination with follicle miniaturisation. The trigger oral spironolactone is a novel therapy for miniaturisation remains unclear Psychological morbidity with promising results. The role of but is postulated to be a combination the general practitioner is paramount of genetic predisposition, androgen FPHL is less well understood and accepted in establishing the diagnosis, setting influence and other not yet elucidated by society than alopecia in males. This achievable therapeutic goals and factors. Androgens exert their effect on generates feelings of greater confusion navigating the psychosocial comorbidity hair via circulating levels of testosterone, and distress for female patients. A study associated with this chronic condition. which is produced in females by the showed that 52% of women were very- ovaries and adrenal glands. The free to-extremely upset by their hair loss, testosterone either binds to intracellular compared with 28% of men.1 In another androgen receptors in the hair bulb, questionnaire, 70% of surveyed women causing follicular miniaturisation, or is with hair loss had a negative body image metabolised by enzyme 5-alpha reductase and poorer self-esteem, with poorer into dihydrotestosterone (DHT). DHT sleep, feelings of guilt and restriction and testosterone both bind to the same of social activities.3 Clinicians should androgen receptors, but DHT does so also screen for maladaptive coping with more affinity, leading to increased mechanisms such as compulsive fixing miniaturisation.3,5,6 of one’s hair and underlying psychiatric trichotillomania.1,10,11 Female pattern hair loss and general health Assessment As alopecia is highly visible, a patient may The diagnosis of FPHL is made on clinical 4,5 note hair loss as the first symptom of a grounds. © The Royal Australian College of General Practitioners 2018 REPRINTED FROM AJGP VOL. 47, NO. 7, JULY 2018 | 459 CLINICAL FEMALE PATTERN HAIR LOSS History menopause has occured and, if so, at Treatment Classically, the pattern of alopecia which age; use of hormonal contraception; begins with hair density reduction on the fertility concerns and any previous Key points of counselling and non- mid-frontal hairline. The anterior part gynaecological surgery.1,3,5 A discussion pharmacological treatment options are width then widens, resulting in prominent of pregnancy plans is necessary as some outlined in Figure 2. Pharmacological thinning in a Christmas tree pattern. treatments are teratogenic.1 Generalised and rapid shedding with global hair thinning is unusual and points Family history Table 1. Key features in history taking to other causes such as hyperadrenalism, Fifty-four per cent of patients have a first- and examination for detection of medication exposure, major stressors degree male relative of age >30 years with underlying systemic illnesses1,6,10 or change in hair care practices.1,3,6,10,11 alopecia, and 21% have a first-degree Hair loss over the temporal region is female relative aged >30 years with Underlying systemic diseases that may uncommon in FPHL, compared with male FPHL. An Australian gene-wide study present with alopecia pattern alopecia. If temporal thinning of Caucasian women suggested that • Virilising tumours was the first symptom, telogen effluvium, aromatase gene CYP19A1 may contribute • Polycystic ovarian syndrome frontal fibrosing alopecia, tractional to FPHL.3 • Hyperandrogenism +/– associated alopecia and hypothyroidism should be metabolic syndrome considered.6 Symptoms of scalp pruritus, Examination • Thyroid dysfunction burning and pain point to another General observations for body habitus, • Systemic lupus erythematosus (SLE) • Dermatomyositis diagnosis (Table 1).6 acne, hirsutism and acanthosis nigricans After diagnosing FPHL, concurrent should be made. Focused examination • Iron deficiency +/– anaemia medical illnesses that exacerbate alopecia should identify the calibre of the hairs and • Caloric restriction: anorexia/bulimia should be ruled out to improve overall the location of the affected areas. Findings • Psychiatric disorder: trichotillomania outcome. These include iron deficiency, consistent with FPHL include: • Medication/toxin exposure or ingestion infection, thyroid dysfunction and • loss of terminal hair in the mid-frontal • Infection: syphilis 3,11 nutritional deficiencies. Occupational scalp Red flags on history taking for history and exposure to, or ingestion of, • normal hair density in occiput regions underlying systemic illnesses toxic chemicals should be elicited.10 and preserved frontal hairline1,6 • Generalised and rapid hair shedding • miniaturised hairs: hair of various • Lateral eyebrow hair loss/thinning Gynaecological history lengths and diameters in thinning • Menstrual irregularity, fertility difficulty A detailed gynaecological history is areas3,6 • Severe acne necessary to rule out hyperandrogenism, • widening of central part with diffuse • Marked hirsutism polycystic ovarian syndrome or a reduction in hair density in a Christmas • Associated cutaneous eruption virilising tumour as underlying diagnoses. tree pattern1,11 • New photosensitivity History should include age of menarche; • normal-appearing scalp • Severe fatigue menstrual cycle details; whether • negative hair pull test: hold a bundle of • Weight changes: gain or loss 60 hairs close to the scalp between the • Fevers or chills thumb, index and middle finger. The • Joint and muscle aches test is positive when more than three • Severe psychological stressors hairs can be pulled away.12 Non-classic symptoms and signs that Examination findings suggestive of underlying disorders suggest other types of alopecia are • SLE: isolated parietal alopecia, scarring outlined in Tables 1 and 2. alopecia (violaceous papules, follicular erythema), associated cutaneous malar Laboratory investigations rash, arthralgia Laboratory testing should be considered • Thyroid dysfunction: temporal region in patients with diffuse alopecia, signs of alopecia, lateral eyebrow hair-loss androgen excess and early-onset FPHL. • Trichotillomania: broken hair shafts Recommended tests and rationale are of variable length, diffuse and patchy outlined in Table 3. Note that testing of hair loss androgen levels needs to occur during the • Endocrinopathy: acanthosis nigricans, hirsutism, truncal acne (especially follicular phase, between the fourth and nodulocystic), high body mass index seventh days of the menstrual cycle, and Figure 1. Female pattern hair loss with • Nutritional deficiency: conjunctival Christmas tree pattern oral contraceptives should be discontinued pallor, glossitis, muscle wasting eight weeks prior to the test.1,3 460 | REPRINTED FROM AJGP VOL. 47, NO. 7, JULY 2018 © The Royal Australian College of General Practitioners 2018 FEMALE PATTERN HAIR LOSS CLINICAL Table 2. History and examination findings of common non-scarring and scarring alopecia disorders6,10,11 Non-scarring alopecia Typical history Examination findings Hair pull (common) Female/male pattern Age: puberty or
Load more

Recommended publications
  • Anatomy and Physiology of Hair
    Chapter 2 Provisional chapter Anatomy and Physiology of Hair Anatomy and Physiology of Hair Bilgen Erdoğan ğ AdditionalBilgen Erdo informationan is available at the end of the chapter Additional information is available at the end of the chapter http://dx.doi.org/10.5772/67269 Abstract Hair is one of the characteristic features of mammals and has various functions such as protection against external factors; producing sebum, apocrine sweat and pheromones; impact on social and sexual interactions; thermoregulation and being a resource for stem cells. Hair is a derivative of the epidermis and consists of two distinct parts: the follicle and the hair shaft. The follicle is the essential unit for the generation of hair. The hair shaft consists of a cortex and cuticle cells, and a medulla for some types of hairs. Hair follicle has a continuous growth and rest sequence named hair cycle. The duration of growth and rest cycles is coordinated by many endocrine, vascular and neural stimuli and depends not only on localization of the hair but also on various factors, like age and nutritional habits. Distinctive anatomy and physiology of hair follicle are presented in this chapter. Extensive knowledge on anatomical and physiological aspects of hair can contribute to understand and heal different hair disorders. Keywords: hair, follicle, anatomy, physiology, shaft 1. Introduction The hair follicle is one of the characteristic features of mammals serves as a unique miniorgan (Figure 1). In humans, hair has various functions such as protection against external factors, sebum, apocrine sweat and pheromones production and thermoregulation. The hair also plays important roles for the individual’s social and sexual interaction [1, 2].
    [Show full text]
  • Fungal Infections from Human and Animal Contact
    Journal of Patient-Centered Research and Reviews Volume 4 Issue 2 Article 4 4-25-2017 Fungal Infections From Human and Animal Contact Dennis J. Baumgardner Follow this and additional works at: https://aurora.org/jpcrr Part of the Bacterial Infections and Mycoses Commons, Infectious Disease Commons, and the Skin and Connective Tissue Diseases Commons Recommended Citation Baumgardner DJ. Fungal infections from human and animal contact. J Patient Cent Res Rev. 2017;4:78-89. doi: 10.17294/2330-0698.1418 Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes, and the patient experience. REVIEW Fungal Infections From Human and Animal Contact Dennis J. Baumgardner, MD Aurora University of Wisconsin Medical Group, Aurora Health Care, Milwaukee, WI; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI; Center for Urban Population Health, Milwaukee, WI Abstract Fungal infections in humans resulting from human or animal contact are relatively uncommon, but they include a significant proportion of dermatophyte infections. Some of the most commonly encountered diseases of the integument are dermatomycoses. Human or animal contact may be the source of all types of tinea infections, occasional candidal infections, and some other types of superficial or deep fungal infections. This narrative review focuses on the epidemiology, clinical features, diagnosis and treatment of anthropophilic dermatophyte infections primarily found in North America.
    [Show full text]
  • Pediatric and Adolescent Dermatology
    Pediatric and adolescent dermatology Management and referral guidelines ICD-10 guide • Acne: L70.0 acne vulgaris; L70.1 acne conglobata; • Molluscum contagiosum: B08.1 L70.4 infantile acne; L70.5 acne excoriae; L70.8 • Nevi (moles): Start with D22 and rest depends other acne; or L70.9 acne unspecified on site • Alopecia areata: L63 alopecia; L63.0 alopecia • Onychomycosis (nail fungus): B35.1 (capitis) totalis; L63.1 alopecia universalis; L63.8 other alopecia areata; or L63.9 alopecia areata • Psoriasis: L40.0 plaque; L40.1 generalized unspecified pustular psoriasis; L40.3 palmoplantar pustulosis; L40.4 guttate; L40.54 psoriatic juvenile • Atopic dermatitis (eczema): L20.82 flexural; arthropathy; L40.8 other psoriasis; or L40.9 L20.83 infantile; L20.89 other atopic dermatitis; or psoriasis unspecified L20.9 atopic dermatitis unspecified • Scabies: B86 • Hemangioma of infancy: D18 hemangioma and lymphangioma any site; D18.0 hemangioma; • Seborrheic dermatitis: L21.0 capitis; L21.1 infantile; D18.00 hemangioma unspecified site; D18.01 L21.8 other seborrheic dermatitis; or L21.9 hemangioma of skin and subcutaneous tissue; seborrheic dermatitis unspecified D18.02 hemangioma of intracranial structures; • Tinea capitis: B35.0 D18.03 hemangioma of intraabdominal structures; or D18.09 hemangioma of other sites • Tinea versicolor: B36.0 • Hyperhidrosis: R61 generalized hyperhidrosis; • Vitiligo: L80 L74.5 focal hyperhidrosis; L74.51 primary focal • Warts: B07.0 verruca plantaris; B07.8 verruca hyperhidrosis, rest depends on site; L74.52 vulgaris (common warts); B07.9 viral wart secondary focal hyperhidrosis unspecified; or A63.0 anogenital warts • Keratosis pilaris: L85.8 other specified epidermal thickening 1 Acne Treatment basics • Tretinoin 0.025% or 0.05% cream • Education: Medications often take weeks to work AND and the patient’s skin may get “worse” (dry and red) • Clindamycin-benzoyl peroxide 1%-5% gel in the before it gets better.
    [Show full text]
  • Eyelash-Eyebrow Services
    BUSINESS, CONSUMER SERVICES, AND HOUSING AGENCY – GOVERNOR Edmund G. Brown JR. BOARD OF BARBERING AND COSMETOLOGY P.O. Box 944226, Sacramento, CA 94244-2260 P (800) 952-5210 F (916) 575-7281 www.barbercosmo.ca.gov Industry Bulletin - 11/29/17 – Eyelash and Eyebrow Services The California Board of Barbering and Cosmetology would like to remind its licensees of the following information regarding eyelash and eyebrow services. Eyelash Application The practice of applying eyelashes, eyelash extensions, and eyelash strips to any person is only within the scope of practice of licensed cosmetologists and estheticians. As stated in section 7316 of the California Business and Professions Code in part reads as follows: (c) Within the practice of cosmetology there exist the specialty branches of skin care and nail care. (1) Skin care is any one or more of the following practices: (A) Giving facials, applying makeup, giving skin care, removing superfluous hair from the body of any person by the use of depilatories, tweezers or waxing, or applying eyelashes to any person. Eyelash Perming The practice of eyelash perming is only within the scope of practice of licensed cosmetologists and barbers as stated in section 7316 of the California Business and Professions Code which in part reads: (a) The practice of barbering is all or any combination of the following practices: (3) Singeing, shampooing, arranging, dressing, curling, waving, chemical waving, hair relaxing, or dyeing the hair or applying hair tonics. (b) The practice of cosmetology is all or any combination of the following practices: (1) Arranging, dressing, curling, waving, machineless permanent waving, permanent waving, cleansing, cutting, shampooing, relaxing, singeing, bleaching, tinting, coloring, straightening, dyeing, applying hair tonics to, beautifying, or otherwise treating by any means, the hair of any person.
    [Show full text]
  • Hair Shed Research EPD 09/02/2021
    Hair Shed Research EPD 09/02/2021 Registration No. Name Birth Yr HS EPD HS Acc HS Prog 7682162 C R R Emulous 26 17 1972 +.73 .58 42 9250717 Q A S Traveler 23-4 1978 +.64 .52 9891499 Tehama Bando 155 1980 +.26 .54 10095639 Emulation N Bar 5522 1982 +.32 .48 5 10239760 Paramont Ambush 2172 1982 +.47 .44 2 10705768 R R Traveler 5204 1985 +.61 .44 3 10776479 N Bar Emulation EXT 1986 +.26 .76 42 10858958 D H D Traveler 6807 1986 +.40 .67 15 10988296 G D A R Traveler 71 1987 +.54 .40 1 11060295 Finks 5522-6148 1988 +.66 .47 4 11104267 Bon View Bando 598 1988 +.31 .54 1 11105489 V D A R New Trend 315 1988 +.52 .51 1 11160685 G T Maximum 1988 +.76 .46 11196470 Schoenes Fix It 826 1988 +.75 .44 5 11208317 Sitz Traveler 9929 1989 +.46 .43 3 11294115 Papa Durabull 9805 1989 +.18 .42 3 11367940 Sitz Traveler 8180 1990 +.60 .53 3 11418151 B/R New Design 036 1990 +.48 .74 35 11447335 G D A R Traveler 044 1990 +.57 .44 11520398 G A R Precision 1680 1990 +.14 .62 1 11548243 V D A R Bando 701 1991 +.29 .45 8 11567326 V D A R Lucys Boy 1990 +.58 .40 1 11620690 Papa Forte 1921 1991 +1.09 .47 7 11741667 Leachman Conveyor 1992 +.55 .40 2 11747039 S A F Neutron 1992 +.44 .45 2 11750711 Leachman Right Time 1992 +.45 .69 27 11783725 Summitcrest Hi Flyer 3B18 1992 +.11 .44 4 11928774 B/R New Design 323 1993 +.33 .60 9 11935889 S A F Fame 1993 +.60 .45 1 11951654 Basin Max 602C 1993 +.97 .59 16 12007667 Gardens Prime Time 1993 +.56 .41 1 12015519 Connealy Dateline 1993 +.41 .55 4 12048084 B C C Bushwacker 41-93 1993 +.78 .67 28 12075716 Leachman Saugahatchee 3000C 1993 +.66 .40 3 12223258 J L B Exacto 416 1994 -.22 .51 3 12241684 Butchs Maximum 3130 1993 +.75 .45 7 12309326 SVF Gdar 216 LTD 1994 +.60 .48 2 12309327 GDAR SVF Traveler 234D 1994 +.70 .45 5 Breed average EPD for HS is +0.54.
    [Show full text]
  • Isotretinoin Induced Periungal Pyogenic Granuloma Resolution with Combination Therapy Jonathan G
    Isotretinoin Induced Periungal Pyogenic Granuloma Resolution with Combination Therapy Jonathan G. Bellew, DO, PGY3; Chad Taylor, DO; Jaldeep Daulat, DO; Vernon T. Mackey, DO Advanced Desert Dermatology & Mohave Centers for Dermatology and Plastic Surgery, Peoria, AZ & Las Vegas, NV Abstract Management & Clinical Course Discussion Conclusion Pyogenic granulomas are vascular hyperplasias presenting At the time of the periungal eruption on the distal fingernails, Excess granulation tissue and pyogenic granulomas have It has been reported that the resolution of excess as red papules, polyps, or nodules on the gingiva, fingers, the patient was undergoing isotretinoin therapy for severe been described in both previous acne scars and periungal granulation tissue secondary to systemic retinoid therapy lips, face and tongue of children and young adults. Most nodulocystic acne with significant scarring. He was in his locations.4 Literature review illustrates rare reports of this occurs on withdrawal of isotretinoin.7 Unfortunately for our commonly they are associated with trauma, but systemic fifth month of isotretinoin therapy with a cumulative dose of adverse event. In addition, the mechanism by which patient, discontinuation of isotretinoin and prevention of retinoids have rarely been implicated as a causative factor 140 mg/kg. He began isotretinoin therapy at a dose of 40 retinoids cause excess granulation tissue of the skin is not secondary infection in areas of excess granulation tissue in their appearance. mg daily (0.52 mg/kg/day) for the first month and his dose well known. According to the available literature, a course was insufficient in resolving these lesions. To date, there is We present a case of eruptive pyogenic granulomas of the later increased to 80 mg daily (1.04 mg/kg/day).
    [Show full text]
  • Contra Indications, Aftercare & Homecare for Tinting Treatments
    Contra Indications, Aftercare & Homecare For Tinting Treatments Contra- Indications If there has been any reaction to the patch test, Blepharitis- The eyes are red, irritated and itchy, with treatment will be contraindicated dandruff-like crusts appearing on the eyelashe/hes. Conjunctivitis Styes Hay fever Watery eye Any Skin irritation or hypersensitivity around the eye Any eye surgery (approximately 6 months) Cuts, bruises and abrasions. Very nervous client Recent scar tissue. Infectious and non-infectious skin conditions specific to the eye and surrounding area to include: Atopic eczema Atopic dermatitis Psoriasis Contact lenses must be removed Pre-Care The client should be advised not to wear mascara when coming to the salon for any tinting treatment. After Care The following Information should be given to each client who is having a tinting treatment: Avoid rubbing the eyes Avoid heat treatments for 24 hours Avoid sunbathing for 24 hours, as this fades the tint Avoid putting your contact lenses back in for the rest of the day Although we make sure every trace of dye is removed, it is possible that residues may remain Do not apply make-up or receive any other eye treatments for at least 24 hours after your treatment. No perfumed products or lotions ( if the eyebrows have been shaped) Apply after-wax or aloe vera to soothe the skin if required, at home Try not to tweeze the eyebrows between treatments as this may change the shape of the brow and causes the hair growth cycle to change. Home care Sterex Aloe Vera- Pure aloe vera to soothe the skin at home Gi Gi Post Wax Cooling Gel – Contains cucumber, aloe vera, glycerine and menthol to sooth the skin and reduce redness.
    [Show full text]
  • Also Called Androgenetic Alopecia) Is a Common Type of Hereditary Hair Thinning
    750 West Broadway Suite 905 - Vancouver BC V5Z 1H8 Phone: 604.283.9299 Fax: 604.648.9003 Email: [email protected] Web: www.donovanmedical.com Female Pattern Hair Loss Female pattern hair loss (also called androgenetic alopecia) is a common type of hereditary hair thinning. Although hair may become quite thin, women do not become bald as in men. Hair thinning starts as early as the teenage years, but usually in the twenties and thirties and is usually fully expressed by the age of 40. How can one recognize female pattern hair loss? § Typically, a female in her teens, twenties or thirties gradually becomes aware that she has less hair on the top of her head than previously. § She may notice that her scalp has become slightly visible now and it takes more effort to style the hair to hide the thinning. § The size of the ponytail becomes smaller in diameter. § While all this is happening, she may also notice that her hair becomes greasy and stringy more quickly and she shampoos more often to keep the hair looking fuller volume. § One of the earliest signs of androgenetic alopecia is widening of the ‘central part’ (down the middle of the scalp). The spacing between hairs gradually increases. The thinning gradually becomes diffuse and may be present all over the scalp but is usually most pronounced over the top and sides of the head. § There is much variation in the diameter and length of hairs – some and thick and long while others are fine and short. This variation in size represents the gradual miniaturization of hair follicles- they become smaller and smaller.
    [Show full text]
  • Alopecia Areata Part 1: Pathogenesis, Diagnosis, and Prognosis
    Clinical Review Alopecia areata Part 1: pathogenesis, diagnosis, and prognosis Frank Spano MD CCFP Jeff C. Donovan MD PhD FRCPC Abstract Objective To provide family physicians with a background understanding of the epidemiology, pathogenesis, histology, and clinical approach to the diagnosis of alopecia areata (AA). Sources of information PubMed was searched for relevant articles regarding the pathogenesis, diagnosis, and prognosis of AA. Main message Alopecia areata is a form of autoimmune hair loss with a lifetime prevalence of approximately 2%. A personal or family history of concomitant autoimmune disorders, such as vitiligo or thyroid disease, might be noted in a small subset of patients. Diagnosis can often be made clinically, based on the characteristic nonscarring, circular areas of hair loss, with small “exclamation mark” hairs at the periphery in those with early stages of the condition. The diagnosis of more complex cases or unusual presentations can be facilitated by biopsy and histologic examination. The prognosis varies widely, and poor outcomes are associated with an early age of onset, extensive loss, the ophiasis variant, nail changes, a family history, or comorbid autoimmune disorders. Conclusion Alopecia areata is an autoimmune form of hair loss seen regularly in primary care. Family physicians are well placed to identify AA, characterize the severity of disease, and form an appropriate differential diagnosis. Further, they are able educate their patients about the clinical course of AA, as well as the overall prognosis, depending on the patient subtype. Case A 25-year-old man was getting his regular haircut when his EDITor’s KEY POINTS • Alopecia areata is an autoimmune form of barber pointed out several areas of hair loss.
    [Show full text]
  • Short Anagen Syndrome: a Case Study
    Journal of Cosmetics, Dermatological Sciences and Applications, 2012, 2, 14-15 http://dx.doi.org/10.4236/jcdsa.2012.21004 Published Online March 2012 (http://www.SciRP.org/journal/jcdsa) Short Anagen Syndrome: A Case Study Martina Alés Fernández, Francisco M. Camacho Martínez Department of Dermatology, Virgen Macarena University Hospital, Seville, Spain. Email: [email protected], [email protected] Received October 31st, 2011; revised November 18th, 2011; revised November 29th, 2011 ABSTRACT Short anagen syndrome is a relatively recently described entity. This syndrome is an unusual condition where the ana- gen growth phase of hair follicles is shorter than normal. Its clinical characteristics and trichogram findings contribute to the diagnosis of this trichosis. Keywords: Anagen Syndrome 1. Case Report Three-years-old girl with low density and slow growth scalp hair that had not been cut since birth. Her birth and medical history were unremarkable. The physical ex- amination revealed short and fine brown scalp hair with decreased density in frontoparietal areas (Figure 1). The rest of the physical examination was normal, without any abnormalities in eyelashes, eyebrows, teeth, nails or skin. The hair pull test was negative. The trichogram demon- strated some dystrophic hairs, but the most important data was an increased number of telogen hairs with a consistent decreased number of anagen hairs (Figure 2). The anagen to telogen ratio (7:28) was significantly re- duced with only 25% of hairs in anagen. 2. Discussion Short anagen syndrome is a relatively recently recog- nized entity poorly documented. Short hair due to a short anagen phase was described in 1987 by Kersey as part of tricho-dental syndrome [1].
    [Show full text]
  • Refectocil Product Information Sheets for Your Eyes Only!
    RefectoCil Product information sheets For your eyes only! Contents: RefectoCil Basic tinting products a. RefectoCil Tints b. Starter Kits c. Lash & Brow Bar d. Shelf display e. Floor display Brow Styling Strips Eyelash Curl a. Refill products RefectoCil Sensitive products a. Sensitive Tints b. Sensitive Developer Gel c. Sensitive Tint remover d. Sensitive Starter Kit Accessories a. Eye make-up remover b. Saline solution c. Tint remover d. Skin Protection Cream & Eye Mask e. Oxidant 3% Developer Liquid f. Oxidant 3% Developer Cream g. Application Set Mini h. Artist palette i. Application sticks j. Cosmetic brushes k. Silicone Pads l. Eye protection papers Care a. Longlash balsam b. Styling Gel RefectoCil No. 1 Pure Black Eyelash and Eyebrow Tint, 15 ml. Brilliant Black – create the most beautiful black styles Pure Black No. 1 by RefectoCil is an intense, pure and rich black hue. Enhance sensuous raven-haired looks in a mind-blowing way – with expert colouring by RefectoCil. Long, dark and full eyelashes Perfectly defined eyebrows Lasts up to 6 weeks Content: sufficient for approximately 30 applications Individually customizable colour, 9 base shades, 8 mixable! Target group: RefectoCil No.1 dyes the hair an intense, luscious black • For tinting eyebrows of clients who have very dark, black hair • For tinting lashes of clients who ask for a dramatic eye-catching look Application: Preparation: use RefectoCil Silicone Pads or Skin Protection Cream and Eye protection papers according to instructions. Mix 2 cm of tint and 10 drops of RefectoCil Oxidant liquid or 15-20 drops of RefectoCil Oxidant cream to create a creamy paste.
    [Show full text]
  • Hair Expressions Eyelash Extension Agreement and Consent Form • Come to Your Appointment Having Thoroughly Washed Your Eyes So
    Hair Expressions Eyelash Extension Agreement and Consent Form Name: _____________________________________ Date: _____________________________ Best Contact Number: Cell: _______________________ Work: ____________________________ Home Address: _________________________________________________________________ City: ____________________________ State: __________________ Zip: __________________ Email: _______________________________________________________________________ Referred by: ___________________________________________________________________ I understand that this procedure requires single synthetic eyelashes to be glued to my own natural eyelashes. I understand that it is my responsibility to keep my eyes closed and be still during the entire procedure, until my eyelash technician addresses me to open my eyes. I understand that some risks of this procedure may be but are not limited to eye redness, swelling of eyelids and irritation. The fumes from the adhesive may cause my eyes to water. I agree to disclose any allergies that I may have to latex, surgical tapes, cyanoacrylate, Vaseline, etc. I understand that I am required to follow the eyelash extension care sheet in order to maintain the life of these extensions. I agree that reading and signing this consent form, I release Hair Expressions from any claims or damages of any nature. I agree that I read and fully understand this entire consent form. I am of sound mind and fully capable of executing this waiver for myself. The undersigned confirms receiving, reading and reviewing with the technician the attached Consent Form which forms part of this agreement, I confirm and agree that I wish to engage the services of Hair Expressions to apply Eyelash extensions. Client Signature: _____________________________ Date: _______________________ Eyelash extensions are not for everyone. This is a high-maintenance beauty treatment that requires gentle care for the lashes to remain in good condition and be long-lasting.
    [Show full text]